v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Schedule of Significant Expense Categories Regularly Reviewed by the CODM [Abstract]    
Net revenues $ 46 $ 59
Costs and operating expenses:    
Cost of goods sold 226 153
Research and development 2,748 2,360
Sales and marketing 358 325
General and administrative 1,821 2,105
Total costs and operating expenses 5,153 4,943
Operating loss (5,107) (4,884)
Other income (expense):    
Change in fair value of forward purchase agreement put option liability 103
Change in fair value of forward purchase agreement warrant liability 421 (262)
Change in fair value of publicly traded warrant liability 194 (1,177)
Interest expense, related party (495) (36)
Other expense, net (11) (14)
Total other income (expense), net 109 (1,386)
Net loss (4,998) (6,270)
Cumulative preferred dividends (1,238) (1,365)
Net loss attributable to common stockholders, basic (6,236) (7,635)
Net loss attributable to common stockholders, diluted $ (6,236) $ (7,635)
Net loss per share attributable to common stockholders, basic (in Dollars per share) $ (0.29) $ (0.41)
Net loss per share attributable to common stockholders, diluted (in Dollars per share) $ (0.29) $ (0.41)
Weighted-average outstanding, basic (in Shares) 21,326,609 18,599,982
Weighted-average outstanding, diluted (in Shares) 21,326,609 18,599,982
Other comprehensive income (loss):    
Foreign currency translation adjustment $ 6 $ (1)
Other comprehensive income (loss) 6 (1)
Comprehensive loss $ (4,992) $ (6,271)

Source

10-Q XBRL Zip